Prevalence of diabetes mellitus and correlation of urinary transforming growth facror-β with blood hemoglobin A1C in the atascosa diabetes study

Ethnicity and Disease

Volumn 18, Issue 2 SUPPL. 2, 2008, Pages

  Riojas, Marco A ^c   Villanueva Vedia, Rosa E ^b   Zamilpa, Rogelio ^a   Chen, Xiao ^b   Du, Liem C ^c   Phelix, Clyde F ^a   Lebaron, Richard G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b South West Clinical Laboratory Consulting Co ^*  (Russian Federation)

^c Atascosa Health Center   (United States)

Author keywords

Cytokines; Diabetic nephropathy; Glucose tolerance; Hispanic

Indexed keywords

HEMOGLOBIN A1C; TRANSFORMING GROWTH FACTOR BETA1; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CAUCASIAN; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PREVALENCE; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; URINALYSIS; ANALYSIS OF VARIANCE; BLOOD; GENETIC PREDISPOSITION; MIDDLE AGED; RISK FACTOR; RURAL POPULATION; UNITED STATES; URINE;

ADULT; ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; TEXAS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 52149111884     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? Diabetes Care. 2001;24:2059-2064.
2. Arya R, Blangero J, Williams K, et al. Factors of insulin-resistance syndrome-related phe- notypes are linked to genetic locations of chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes. 2002;51:841 - 847.
3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity- related health risk factors, 2001. JAMA. 2003;289:76-79.
4. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int SuppL 2005;94:S46-S49.
5. Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005;28(9):2280- 2288.
6. Ellis D, Forrest KY, Erbey J, Orchard TJ. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem. 1998;44(5):950- 956.
7. Bertoluci MC, Uebel D, Schmidt A, Thomazelli FC, Oliveira FR, Schmid H. Urinary TGF-beta 1 reduction related to a decrease of systolic blood pressure in parients with type 2 diabetes and clinical diabetic nephtopathy. Diabetes Res Clin Pract. 2006;72(3):258- 264.
8. The Expett Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
9. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2003.
10. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(Suppl1)-.S11-S14.
11. Stern MP, Gonzalez C, Mitchell BD, Villal- pando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes. 1992;41:484-492.
12. Stern MP, Gaskill SP, Hazuda HP, Gardner LI, Haffner SM. Does obesity explain excess prevalence of diabetes among Mexican-Americans? Results of the San Antonio Heart Study. Diabetologia. 1983;24:272-277.
13. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care. 2003;26:3153-3159.
14. American Diabetes Association: Standards of medical cate in diabetes. Diabetes Care. 2004;27(Suppl 1):S15-S35.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5-S10.
16. Haffner SM, Rosenthal M, Hazuda HP, Stern MP, Franco LJ. Evaluation of three potential screening tests for diabetes mellitus in a biethnic population. Diabetes Care. 1984; 7:347-353.
17. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes (technical review). Diabetes Care. 2000;23:1563-1580, (Erratum in Diabetes Care. 2000;23:1868- 1869.)
18. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Srudies. Diabetes. 2003;52:2160-2167.
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356-359.
20. Hatris MI, Flegal KM, Cowie CC, et al. Ptevalence of diabetes, impaired fasting glucose, and impaited glucose toletance in US adults: the Thitd National Health and Nutrition Examination Survey (NHA NES), 1988-94. Diabetes Care. 1998;21: 518-524.